Rasio rega marang bathi Onconetix Corporation (ONCO)

Onconetix, Inc. (ONCO) is developing its business within the early detection niche for malignant prostate tumors by implementing precision diagnostic tools. This historical price chart featuring the -0.10 metric illustrates the dynamics of the company, which maintains its position through exclusive biomarker patents. The enterprise is currently expanding its commercial presence, offering up-to-date methods for detecting dangerous forms of cancer to improve men's health.

ONCO Onconetix: Rasio rega marang bathi ing interval 21.02.2024 - 15.11.2026

Rincian analitis perusahaan Onconetix, Inc.

- rega lan prakiraan konsensus rega:

Rega saham Onconetix Inc|ONCO - Bagan rega target

- rincian kapitalisasi pasar:

Nilai pasar Onconetix Corporation|ONCO - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- informasi kapitalisasi buku:

Nilai Aset Bersih saben Saham Onconetix|ONCO - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku onconetix.gcs-web.com|ONCO - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Koefisien Total Utang marang Modal Onconetix, Inc.|ONCO - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal onconetix.gcs-web.com|ONCO - Utang perusahaan|Utang-utang marang nilai buku Onconetix Corp|ONCO - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Onconetix|Indikator likuiditas cepet onconetix.gcs-web.com

- data bathi bisnis lan rasio investasi:

ONCO - Bathi resik perusahaan|Bathi resik sing dikarepake Onconetix, Inc.|ONCO - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Onconetix Corp|ONCO - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Onconetix Corporation|ONCO - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Onconetix|ONCO - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan onconetix.gcs-web.com|ONCO - Wutah bathi resik saben saham ing taun iki|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Onconetix, Inc.

- indikator volume dodolan lan pendapatan:

ONCO - Dodolan perusahaan|Pendapatan mangsa ngarep perusahaan Onconetix|ONCO - Multiplikator P/S|Rasio kapitalisasi marang dodolan sing dikarepake Onconetix Corp|ONCO - Wutah dodolan YoY sajrone rolas wulan kepungkur

Analisis komprehensif perusahaan:ONCO (Onconetix Inc)

Investors are seeking fundamental value supports by analyzing the market capitalization to net income ratio. This coefficient determines the price per unit of earnings, making it possible to identify asset overvaluation. The P/E trajectory of Onconetix, Inc. (ONCO) visualizes the balance between market expectations and actual business efficiency. For Onconetix, Inc. (ONCO), this metric reflects the monetization potential of the drug Entadfi. This valuation helps determine whether the growth of the urological segment is currently priced into the share value.

Analisis perusahaan pesaing